
Nikhil Shah, DO, is a Urologist and urologic oncologist. Formerly served as the System Chief for Minimally Invasive and Robotic Surgery at Piedmont Health Care, serving concurrently as Chief of Minimal Access and Robotic Surgery at Piedmont Atlanta Hospital. Based in Atlanta, he also is the CEO and Co-Founder of Nephrodite, a medical technology company that has developed a surgically implantable hemofilter that works continuously as a renal replacement device. While in practice, he specialized in urologic oncology, minimally invasive and robotic urologic surgery, and men’s urologic health. His research interests include urologic diagnostics and risk stratification, surgical robotics and minimal access innovation, and health equity in urologic outcomes. A recognized leader in minimally invasive and robotic surgery, Dr. Shah continues to lecture in Urology as well as teach and present globally. He earned his medical degree from A.T. Still University Kirksville College of Osteopathic Medicine, completed his urology residency at Henry Ford Health System, and pursued fellowship training at the Vattikutt Urology Institute. In addition, he spent 2 years in training as an NIH-NIDDK Urologist-Scientist Research Scholar. He holds an MPH in Health Management & Health Policy from the University of Michigan School of Public Health.
Professor
Medical School
1993 – 1997
Residency
2006
Fellowship
2004 – 2005